Q2 2026 Astera Labs Inc Earnings Call Transcript

Aug 04, 2026 / 08:30PM GMT
Release Date Price: MXN5659.2

Key Points

Positve
  • Record Q2 revenue of $392.4 million, up 27% sequentially and 104% year-over-year, driven by broad-based strength across the product portfolio.
  • Scorpio AI Fabric switches achieved volume production, with Scorpio expected to become the largest product family in Q3, one quarter ahead of expectations.
  • Strong growth in Aries signal conditioning products, with PCIe 6 revenue now representing over 50% of total company revenue, up from one-third in Q1.
  • Expansion into new markets with Taurus smart cable modules for 800G Ethernet and new 200G per lane retimers/re-drivers, doubling the Taurus portfolio market opportunity to over $4 billion by 2030.
  • CXL momentum with a new design win for Leo memory controllers at a US hyperscaler, with volume shipments expected in 2027 for both standard and custom solutions.
  • Optical connectivity strategy on track, with high-density fiber attach solutions and NPO chipsets targeted for 2027 production, and CPO-enabled Scorpio switches for 2028 and beyond.
  • Strong operating leverage with non-GAAP operating margin expanding to 39.1% in Q2, and expected to reach approximately 43% in Q3.
  • Robust cash position of $1.25 billion, up $68.5 million sequentially, driven by strong cash flow from operations.
  • Diversifying customer base with over 10 customers engaged on Scorpio-X, including new cloud and enterprise opportunities.
  • Software platform Cosmos now enables in-network compute and Hypercast, delivering up to 2x improvement in collective performance, increasing customer stickiness.
Negative
  • Gross margin expected to decline to approximately 72% in Q3 from 73.7% in Q2, due to product mix shifts toward lower-margin switching and module revenue.
  • Heavy reliance on a single lead hyperscaler for Scorpio-X volume production ramp, though additional customers are expected by year-end.
  • China revenue remains in the single digits as a percentage of total revenue, limiting growth potential in that market.
  • CXL revenue is still in early stages, with meaningful volume shipments not expected until 2027, creating uncertainty in near-term contribution.
  • Optical products are still in development, with initial volume production not expected until 2027, posing execution risks.
  • Operating expenses are rising sequentially (up 10% in Q2, and expected to increase further in Q3), reflecting continued investment in R&D and market expansion.
  • The transition to PCIe 6 and Scorpio may lead to margin pressure as new products ramp, with a wide range of margins across use cases.
  • Potential supply chain and manufacturing risks as Scorpio-X ramps to volume production, especially with multiple configurations and customers.
  • Competitive pressures in the AI fabric market, with UALink and other protocols potentially disrupting PCIe-based solutions.
  • Forward-looking guidance assumes continued strong demand, but any slowdown in hyperscaler AI infrastructure spending could impact growth.
Operator

Good afternoon. My name is Holly, and I will be your conference operator today. At this time, I would like to welcome everyone to the Astera Labs Q2 2026 earnings conference call. (Operator Instructions)

I will now turn the call over to Leslie Green, Investor Relations for Astera Labs. Leslie, you may begin.

Leslie Green
Astera Labs Inc - Investor Relations

Thank you, Holly, and good afternoon, everyone, and welcome to the Astera Labs second-quarter 2026 earnings conference call. Joining us on the call today is Jitendra Mohan, Chief Executive Officer and Co-Founder; Sanjay Gajendra, President and Chief Operating Officer and Co-Founder; and Desmond Lynch, Chief Financial Officer.

Before we get started, I would like to remind everyone that certain comments made in this call today may include forward-looking statements regarding, among other things, expected future financial results, strategies, and plans future operations and the markets in which we operate.

These forward-looking statements reflect management's current beliefs,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot